In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors at 3 institutions in 1 country.
Ricardo Usategui-MartínDepartment of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.ORCID 0000-0001-7699-4388 Nadia Galindo-CabelloDepartment of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.ORCID 0000-0001-8721-5220 José María Fernández-GómezDepartment of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.
Álvaro Del RealDepartment of Medicine and Psychiatry, Faculty of Medicine, Valdecilla Research Institute (IDIVAL), University of Cantabria, 39011 Santander, Spain.ORCID 0000-0002-1057-461X Diego FerreñoLaboratory of the Materials Science and Engineering Division-LADICIM, Faculty of Civil Engineering, University of Cantabria, 39011 Santander, Spain.ORCID 0000-0003-3533-1881 Rebeca LapresaInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, 37008 Salamanca, Spain.ORCID 0000-0001-8901-3972 Francisco Martín-RodriguezDepartment of Medicine, Dermatology and Toxicology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.
José A RianchoDepartment of Medicine and Psychiatry, Faculty of Medicine, Valdecilla Research Institute (IDIVAL), University of Cantabria, 39011 Santander, Spain.
Ángeles AlmeidaInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, 37008 Salamanca, Spain.ORCID 0000-0003-0485-8904 José Luis Pérez-CastrillónDepartment of Medicine, Dermatology and Toxicology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.
Universidad de Valladolid · ESUniversidad de Cantabria · ESUniversidad de Salamanca · ES
Funding
Instituto de Salud Carlos III PI21/00727Ministerio de Ciencia e Innovación PID2020-114585RA-I00
6 · The paper itselfAbstract
Metabolic bone diseases cover a broad spectrum of disorders that share alterations in bone metabolism that lead to a defective skeleton, which is associated with increasing morbidity, disability, and mortality. There is a close connection between the etiology of metabolic bone diseases and genetic factors, with
Indexed as
Bone Diseases, MetabolicTumor Suppressor Protein p53AnimalsBiomarkersBone and BonesCase-Control StudiesGenetic Predisposition to DiseaseHumansMicePolymorphism, Single NucleotideBiomarkersTumor Suppressor Protein p53apoptosis and gene polymorphismmetabolic bone diseasesosteoporosisp53TP53
Identifiers
PMID38338673
PMCPMC10855390
OpenAlexW4391170523
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390